TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN UPDATED ANALYSIS OF INFECTION RATES IN THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAMME

Kevin L. Winthrop  1     Edward V. Loftus Jr.  2     Daniel C. Baumgart  3     Ailsa L Hart  4     OTHMAN ALHARBI  5     Leonardo Salese  6     Nervin Lawendy  7     Rajiv Mundayat     Chinyu Su     Walter Reinisch    
1 Oregon Health & Science University,Portland,United States
2 Mayo Clinic,Rochester,United States
3 University of Alberta,Edmonton,Canada
4 St. Mark's Hospital,London,United Kingdom
5 King Khalid University Hospital, King Saud University,Riyadh,Saudi Arabia
6 Pfizer Inc,Collegeville,United States
7 Pfizer Inc,Collegeville,United States;;

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing